Clinical trial · Observational
Feasibility of Remote Activity Assessment and PRO Collection Among Transgender Cancer Survivors
Study to Remotely Monitor Activity in Transgender Cancer Survivors
NCT05391217CI-TRIAL-00080208STRIDEunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Prospective observational feasibility study to evaluate the role of wearable activity monitors to determine the feasibility and acceptability of remote monitoring using wearable technology and PROs to monitor fatigue and physical function in transgender cancer patients and survivors.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Chronic Disease | — | UNRESOLVED | — |
| Neoplasms | Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Remote assessment of patient reported outcomes and daily activity | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Transgender people with history of cancer
- description
- Self-reported cancer history and/or treatment for cancer within the last 5 years.
- interventionNames
- Other: Remote assessment of patient reported outcomes and daily activity
- label
- Transgender people without history of cancer
- description
- People living with other chronic conditions
- interventionNames
- Other: Remote assessment of patient reported outcomes and daily activity
Primary outcomes (1)
- measure
- Feasibility of Remote Activity Assessment and PRO Collection
- timeFrame
- 2 weeks
- description
- Proportion of patients who consent to participate in the research study and complete the baseline fatigue assessment, where a proportion of 50% will be considered feasible.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Self-identifies as transgender person with a history of cancer or receiving treatment for cancer in the last five years from screening for the current study (case) OR self-identifies as transgender person without a history of cancer (control) * 18 years or older * Ambulatory (use of walking aids, such as cane and rollator, is acceptable) * Access to a device (e.g., smartphone, tablet, iPhone) that has the capability to sync to the Fitbit * Have an understanding, ability, and willingness to fully comply with study procedures and restrictions * Can read and understand English, Spanish, or Tagalog (for participant surveys and interviews) * Informed consent obtained from subject and ability for subject to comply with the requirements of the study. Exclusion Criteria: * Any person that does not meet the listed criteria above * Using a pacemaker, implantable cardiac defibrillator, neurostimulator, implantable hearing aids, cochlear implants, or other electronic medical equipment\*. However, removable hearing aids are permitted.
References
Publications (0)
Data not yet available
No reference posted for this study.